A5086789659- Cervical Cancer and HPV Research
- Reproductive tract infections research
- Pelvic floor disorders treatments
- Urinary Tract Infections Management
- Reproductive Health and Contraception
- Sexual function and dysfunction studies
- Pregnancy and Medication Impact
- Hepatitis B Virus Studies
- Syphilis Diagnosis and Treatment
- Sex work and related issues
- Maternal Mental Health During Pregnancy and Postpartum
- Ovarian function and disorders
- Ovarian cancer diagnosis and treatment
- Urological Disorders and Treatments
- Urinary and Genital Oncology Studies
- Pharmacological Effects and Toxicity Studies
- Menopause: Health Impacts and Treatments
- Reproductive System and Pregnancy
- Adolescent Sexual and Reproductive Health
- Endometriosis Research and Treatment
- Pediatric Urology and Nephrology Studies
- Electrolyte and hormonal disorders
- Hepatitis C virus research
- HIV/AIDS Research and Interventions
- Colorectal and Anal Carcinomas
Luigi Sacco Hospital
1991-2007
University of Milan
1991-2007
Istituto Superiore di Sanità
2005
Mario Negri Institute for Pharmacological Research
1993
Introduction Nausea and vomiting in pregnancy (NVP) affect approximately 70–85% of pregnant women, starting between weeks 6 8 often subsiding by week 20. This study evaluates the therapeutic approaches Italian gynecologists treatment NVP. In healthcare system, play a central role prenatal care are primary providers for unlike other countries where midwives may have more prominent role. Methods From June to September 2022, survey was conducted during 15 scientific conferences. The...
Background Norgestimate (NGM) is a progestin with negligible androgenic activity that available in combination ethinyl estradiol (EE) as monophasic combined oral contraceptive (COC). It has been more than 30 years since clinical study evaluated the effects of NGM/EE on menstrual cycle characteristics healthy women, and interim, there growing recognition trials contraceptives should evaluate wide range potential positive negative impacts for users. Objective The aim this to investigate...
We analyzed survivin as a marker of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HR-HPV) predictor HPV clearance disease outcome in cancer 302 samples (squamous cell carcinomas [SCCs], 150; CIN lesions, 152) by immunohistochemical staining with antibody testing using polymerase chain reaction. HR-HPV types were associated closely SCC. There was significant linear relationship between grade intensity expression (P = .0001). Survivin overexpression also strongly...
ObjectivesDuring menopausal transition, women are frequently affected by vulvovaginal atrophy (VVA), due to the decline of estrogen levels. Resulting symptoms itching, burning, dyspareunia, and vaginal dryness (reported in up 85%). The aim this trial was verify if medical device polycarbophil (PCV) moisturizer gel is not less effective than hyaluronic acid (HA) treating dryness.Material methodsThis a multicenter, open label, randomized, parallel group, comparative study with non-inferiority...
Abstract The objectives of this prospective multicentre international cohort study are to describe the characteristics a HIV‐1 positive women and determine best management system by comparing cervical pathology according results cytology, colposcopy human papillomavirus (HPV) testing at baseline throughout follow‐up. A. Cohorts known HIV‐positive were recruited from 6 hospital‐based European centres community‐based South African centre. Following registration, reviewed every months undergo...
Nausea and vomiting in pregnancy is a common invalidating condition early pregnancy. However, no data are available on its prevalence Italy. This survey aims to evaluate the impact of nausea during quality life Italian women.The was performed three public University Hospitals two distinct periods: first interview took place between 18th 22nd week pregnancy, using Questionnaire for Pregnancy Period (14 questions regarding demographic 30 about including Pregnancy-Unique Quantification Emesis...
We analyzed survivin as a marker of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HR-HPV) predictor HPV clearance disease outcome in cancer 302 samples (squamous cell carcinomas [SCCs], 150; CIN lesions, 152) by immunohistochemical staining with antibody testing using polymerase chain reaction. HR-HPV types were associated closely SCC. There was significant linear relationship between grade intensity expression (P = .0001). Survivin overexpression also strongly...
BACKGROUND: The effectiveness of a new vaginal medical device, which contains polycarbophil, 0.04% lauryl glucoside and glycerides (Polybactum®, Effik Italia Spa, Cinisello Balsamo, Milan, Italy), in reducing BV recurrence rate was investigated.METHODS: This multicenter, open label, not comparative study. Women over 18 years old affected by recurrent were included. latest episode diagnosed Amsel criteria 6-9 days before the start study treated with metronidazole (gel 0.75% mg for 5 or ovules...
Recurrent bacterial vaginosis (RBV) after antibiotic treatment has relapse rates of 35% within 3 months and 60% 12 months. A medical device containing polycarbophil, lauryl glucoside, glycerides (PLGG) inhibits growth mucoadhesive properties. This study examined the efficacy in women with RBV.
This TRIPLE study was aimed to evaluate the efficacy of polycarbophil vaginal gel (PCV) in treating symptoms atrophy (VA) peri- and post-menopausal women.
<sec> <title>BACKGROUND</title> Norgestimate (NGM) is a progestin with negligible androgenic activity that available in combination ethinyl estradiol (EE) as monophasic combined oral contraceptive (COC). It has been more than 30 years since clinical study evaluated the effects of NGM/EE on menstrual cycle characteristics healthy women, and interim, there growing recognition trials contraceptives should evaluate wide range potential positive negative impacts for users. </sec>...
The medical literature has reported that recurrent bacterial vaginosis (RBV) a relapse rate of 35% within 3 months and 60% 12 after antibiotic administration. Products are able to provide barrier effect against the biofilm produced by Gardnerella vaginalis could play role in improving results (BV) treatment.This study aims assess performance safety device (Polybactum) containing polycarbophil, lauryl glucoside, glycerides (PLGG) for reducing recurrence BV.The includes women who aged above 18...
ABSTRACT Several risk factors have been identified but the etiology and pathogenesis of Bacterial vaginosis (BV) are still not completely understood, recurrence rate BV remains high despite adequate chemotherapy treatment. The primary objective study was to assess effectiveness a new vaginal medical device, which contains polycarbophil, 0.04 % lauryl glucoside, glycerides (Polybactum ® – Effik Italia), in reducing rate. This multicenter, open label, comparative performed Italy Romania....
Recurrent bacterial vaginosis (RBV) after antibiotic treatments has a relapse rate of 35% within 3 months and 60% 12 months. Products containing polycarbophil (PLGG), that inhibits growth mucoadhesive property, can impair biofilm formation. Here are shown the results POLARIS (Polybactum&reg; to assess Bacterial Vaginosis) study. The first phase was an interventional, open-label, non-controlled, multicentre trial enrolling 56 women in Italy Romania. second observational 10-month follow-up...
<sec> <title>BACKGROUND</title> The medical literature has reported that recurrent bacterial vaginosis (RBV) a relapse rate of 35% within 3 months and 60% 12 after antibiotic administration. Products are able to provide barrier effect against the biofilm produced by <i>Gardnerella vaginalis</i> could play role in improving results (BV) treatment. </sec> <title>OBJECTIVE</title> This study aims assess performance safety device (Polybactum) containing polycarbophil, lauryl...